NCT04289389

Brief Summary

To investigate and make valid estimates of the occurrence of dementia and the most common subtypes of dementia in Trøndelag, and transfer these figures to estimates of the occurrence of dementia in Norway as a whole, by age, sex and severity of dementia. Furthermore, the proportion of people without dementia diagnosis among those with dementia will be examined. The investigators will further investigate whether there are differences in dementia prevalence between males and females and educational groups and look at factors associated with a lack of diagnosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11,675

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

February 6, 2020

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 28, 2020

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2026

Completed
Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

8.3 years

First QC Date

February 6, 2020

Last Update Submit

April 7, 2026

Conditions

Keywords

PrevalenceEpidemiologyAlzheimer's disease

Outcome Measures

Primary Outcomes (1)

  • Dementia criteria in DSM-5

    Used to assess prevalence of dementia in the study population

    Each participant is evaluated against dementia criteria in DSM- after participation, based on assessment done in the 20 month long assessment period

Secondary Outcomes (8)

  • Montreal Cognitive Assessment

    Each participant were assessed once during an assessment period of 20 months

  • CERAD Ten-word test

    Each participant is assessed once during an assessment period of 20 months

  • Severe Impairment Battery

    Participants in institution with known moderate to severe dementia is assessed once during an assessment period of 20 months

  • Hospital Anxiety and Depression Scale

    Each participant is assessed once during an assessment period of 20 months.

  • Instrumental Activities in Daily Living Scale

    Assessed in proxy interview during interview period of 22 months

  • +3 more secondary outcomes

Study Arms (2)

HUNT4 70+

All inhabitants in Nord-Trøndelag 70 years of age and older were invited.

HUNT4 Trondheim 70+

All inhabitants of one district in Trondheim 70 years of age and older were invited.

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Persons of 70 years of age or older participated in HUNT4 and accepted cognitive screening in HUNT4 70+.

You may qualify if:

  • Living in the designated area

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Norwegian National Advisory Unit on Ageing and Health

Tønsberg, Norway

Location

Related Publications (4)

  • Engedal K, Gjora L, Benth JS, Wagle J, Ronqvist TK, Selbaek G. The Montreal Cognitive Assessment: Normative Data from a Large, Population-Based Sample of Cognitive Healthy Older Adults in Norway-The HUNT Study. J Alzheimers Dis. 2022;86(2):589-599. doi: 10.3233/JAD-215442.

    PMID: 35094994BACKGROUND
  • Gjora L, Strand BH, Engedal K, Ernstsen L, Myrstad C, Skjellegrind H, Thingstad P, Selbaek G. Dementia and mild cognitive impairment in older people in Trondelag. Tidsskr Nor Laegeforen. 2023 Jun 26;143(10). doi: 10.4045/tidsskr.22.0815. Print 2023 Jun 27. English, Norwegian.

    PMID: 37376934BACKGROUND
  • Wagle J, Selbaek G, Benth JS, Gjora L, Ronqvist TK, Bekkhus-Wetterberg P, Persson K, Engedal K. The CERAD Word List Memory Test: Normative Data Based on a Norwegian Population-Based Sample of Healthy Older Adults 70 Years and Above. The HUNT Study. J Alzheimers Dis. 2023;91(1):321-343. doi: 10.3233/JAD-220672.

    PMID: 36404547BACKGROUND
  • GjOra L, Strand BH, Bergh S, Borza T, Braekhus A, Engedal K, Johannessen A, Kvello-Alme M, Krokstad S, Livingston G, Matthews FE, Myrstad C, Skjellegrind H, Thingstad P, Aakhus E, Aam S, Selbaek G. Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study. J Alzheimers Dis. 2021;79(3):1213-1226. doi: 10.3233/JAD-201275.

Related Links

MeSH Terms

Conditions

DementiaAlzheimer Disease

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersTauopathiesNeurodegenerative Diseases

Study Officials

  • Geir Selbæk, PhD

    Norwegian National Advisory Unit on Ageing and Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2020

First Posted

February 28, 2020

Study Start

January 1, 2018

Primary Completion

April 7, 2026

Study Completion

April 7, 2026

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations